Chemoinformaics analysis of Oxacycloheptadecan-2-one
Molecular Weight | 254.414 | nRot | 0 |
Heavy Atom Molecular Weight | 224.174 | nRig | 18 |
Exact Molecular Weight | 254.225 | nRing | 1 |
Solubility: LogS | -6.432 | nHRing | 1 |
Solubility: LogP | 6.538 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 48.3278 |
nHD | 0 | BPOL | 32.7002 |
QED | 0.568 |
Synth | 2.316 |
Natural Product Likeliness | 0.45 |
NR-PPAR-gamma | 0.163 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.021 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.892 |
MDCK | 0.0000235 |
BBB | 0.255 |
PPB | 0.97064 |
VDSS | 1.533 |
FU | 0.01647 |
CYP1A2-inh | 0.774 |
CYP1A2-sub | 0.184 |
CYP2c19-inh | 0.537 |
CYP2c19-sub | 0.058 |
CYP2c9-inh | 0.243 |
CYP2c9-sub | 0.914 |
CYP2d6-inh | 0.085 |
CYP2d6-sub | 0.075 |
CYP3a4-inh | 0.326 |
CYP3a4-sub | 0.067 |
CL | 5.513 |
T12 | 0.314 |
hERG | 0.28 |
Ames | 0.01 |
ROA | 0.036 |
SkinSen | 0.961 |
Carcinogencity | 0.136 |
EI | 0.979 |
Respiratory | 0.879 |
NR-Aromatase | 0.107 |
Antiviral | Yes |
Prediction | 0.711336 |